Jaguar Health

JAGX NASDAQ
4.960
+0.400
+8.77%
After Hours: 4.870 -0.09 -1.81% 19:58 06/25 EDT
Open
4.550
Prev Close
4.560
High
5.01
Low
4.210
Volume
732.20K
Avg Vol (3M)
315.59K
52 Week High
175.00
52 Week Low
3.890
% Turnover
1.78%
Market Cap
204.60M
1D
5D
1M
3M
1Y
5Y

Company Profile

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
MORE >

Recently

Name
Price
%Change